Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1016/j.ijid.2008.09.014. Epub 2008 Dec 12.
Affiliations
- PMID: 19070525
- DOI: 10.1016/j.ijid.2008.09.014
Free article
Randomized Controlled Trial
Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children
Carlos G Teran et al. Int J Infect Dis. 2009 Jul.
Free article
Abstract
Background: In previous studies, nitazoxanide has demonstrated a cytoprotective effect against rotavirus, reducing the duration of diarrhea in comparison to placebo. We designed a randomized, single-blind, controlled trial in order to assess the effectiveness of nitazoxanide and probiotics in comparison with a control group.
Methods: Seventy-five children aged from 28 days to 24 months, with rotavirus diarrhea, were randomly assigned to receive either oral nitazoxanide (15 mg/kg/day) twice a day for three days, a combination of oral probiotics, 1 g twice a day for five days, or only oral or systemic rehydration solutions. The duration of diarrhea and of hospitalization were the primary outcome measures, and daily stool frequency, vomiting, and fever were some of the secondary outcome measures analyzed.
Results: The median duration of hospitalization was significantly shorter (p = 0.017) in patients who received nitazoxanide (81 h) and probiotics (72 h) compared to patients who received oral rehydration solution alone (108 h). Similarly, the median duration of diarrhea was significantly reduced (p = 0.009) in children who received nitazoxanide (54 h) and probiotics (48 h) compared to the control group (79 h).
Conclusions: Treatment with nitazoxanide and probiotics is effective in the management of children with acute rotavirus diarrhea. Small differences in favor of nitazoxanide were found in comparison with probiotics. Nitazoxanide is an important treatment option for rotavirus diarrhea.
Similar articles
- Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial.
Rossignol JF, Abu-Zekry M, Hussein A, Santoro MG. Rossignol JF, et al. Lancet. 2006 Jul 8;368(9530):124-9. doi: 10.1016/S0140-6736(06)68852-1. Lancet. 2006. PMID: 16829296 Clinical Trial. - Efficacy and Safety of Saccharomyces boulardii in Acute Rotavirus Diarrhea: Double Blind Randomized Controlled Trial from a Developing Country.
Das S, Gupta PK, Das RR. Das S, et al. J Trop Pediatr. 2016 Dec;62(6):464-470. doi: 10.1093/tropej/fmw032. Epub 2016 Jun 9. J Trop Pediatr. 2016. PMID: 27283364 Clinical Trial. - Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children.
Grandy G, Medina M, Soria R, Terán CG, Araya M. Grandy G, et al. BMC Infect Dis. 2010 Aug 25;10:253. doi: 10.1186/1471-2334-10-253. BMC Infect Dis. 2010. PMID: 20735858 Free PMC article. Clinical Trial. - Probiotics and zinc in acute infectious gastroenteritis in children: are they effective?
Salvatore S, Hauser B, Devreker T, Vieira MC, Luini C, Arrigo S, Nespoli L, Vandenplas Y. Salvatore S, et al. Nutrition. 2007 Jun;23(6):498-506. doi: 10.1016/j.nut.2007.03.008. Epub 2007 May 17. Nutrition. 2007. PMID: 17499972 Review. - Probiotics in the prevention and treatment of diarrhea.
Fox CH, Dang G. Fox CH, et al. J Altern Complement Med. 2004 Aug;10(4):601-3. doi: 10.1089/1075553041829253. J Altern Complement Med. 2004. PMID: 15353012 Review. No abstract available.
Cited by
- In vitro Antiviral Activity of Rubia cordifolia Aerial Part Extract against Rotavirus.
Sun Y, Gong X, Tan JY, Kang L, Li D, Vikash, Yang J, Du G. Sun Y, et al. Front Pharmacol. 2016 Sep 13;7:308. doi: 10.3389/fphar.2016.00308. eCollection 2016. Front Pharmacol. 2016. PMID: 27679574 Free PMC article. - Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.
Liu F, Li G, Wen K, Wu S, Zhang Y, Bui T, Yang X, Kocher J, Sun J, Jortner B, Yuan L. Liu F, et al. J Pediatr Gastroenterol Nutr. 2013 Dec;57(6):750-8. doi: 10.1097/MPG.0b013e3182a356e1. J Pediatr Gastroenterol Nutr. 2013. PMID: 24280990 Free PMC article. - Nitazoxanide: a first-in-class broad-spectrum antiviral agent.
Rossignol JF. Rossignol JF. Antiviral Res. 2014 Oct;110:94-103. doi: 10.1016/j.antiviral.2014.07.014. Epub 2014 Aug 7. Antiviral Res. 2014. PMID: 25108173 Free PMC article. Review. - A meta-analysis of the effects of probiotics and synbiotics in children with acute diarrhea.
Yang B, Lu P, Li MX, Cai XL, Xiong WY, Hou HJ, Ha XQ. Yang B, et al. Medicine (Baltimore). 2019 Sep;98(37):e16618. doi: 10.1097/MD.0000000000016618. Medicine (Baltimore). 2019. PMID: 31517810 Free PMC article. - AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.
Preidis GA, Weizman AV, Kashyap PC, Morgan RL. Preidis GA, et al. Gastroenterology. 2020 Aug;159(2):708-738.e4. doi: 10.1053/j.gastro.2020.05.060. Epub 2020 Jun 9. Gastroenterology. 2020. PMID: 32531292 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical